A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1997

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Valganciclovir

DRUG

Ganciclovir

Trial Locations (19)

10016

New York Univ Med Ctr, New York

10019

St Luke's - Roosevelt Hosp Ctr / Div of Infect Dis, New York

10021

New York Hosp - Cornell Med Ctr, New York

20006

Dr Alan Palestine, Washington D.C.

27710

Duke Univ Eye Ctr, Durham

30322

Emory Eye Clinic, Atlanta

33136

Univ of Miami School of Medicine, Miami

78705

Austin Infectious Disease Consultants, Austin

92093

Univ of California / San Diego / Dept of Pediatrics, La Jolla

92103

Univ of California / San Diego Treatment Ctr, San Diego

92697

Univ of California / Irvine, Irvine

94114

Davies Med Ctr / Institute for HIV Research, San Francisco

94115

Kaiser Permanente Med Ctr, San Francisco

QUEST Clinical Research, San Francisco

02111

New England Med Ctr, Boston

Unknown

St Pauls Hosp, Vancouver

The Toronto Hosp / Dept of Infectious Disease, Toronto

Montreal Chest Institute, Montreal

Royal Victoria Hosp, Montreal

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00002377 - A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes | Biotech Hunter | Biotech Hunter